ImportRefusal LogoImportRefusal

First Flight Courier

⚠️ Moderate Risk

FEI: 3003304350 • Dubai • UNITED ARAB EMIRATES

FEI

FEI Number

3003304350

📍

Location

Dubai

🇦🇪
🏢

Address

P O Box 28859, , Dubai, , United Arab Emirates

Moderate Risk

FDA Import Risk Assessment

45.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

12
Total Refusals
2
Unique Violations
12/1/2006
Latest Refusal
2/27/2004
Earliest Refusal

Score Breakdown

Violation Severity
71.8×40%
Refusal Volume
41.3×30%
Recency
0.0×20%
Frequency
43.5×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7512×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

11810×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

Refusal History

DateProductViolationsDivision
12/1/2006
65GAJ99PIGMENTATION AGENT N.E.C.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
12/12/2005
65VCA15DIAZEPAM (SEDATIVE)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
6/16/2005
62SDK99ANTI-SEBORRHEIC N.E.C.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
5/23/2005
66VBL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
4/4/2005
66MDA03ALPRAZOLAM (TRANQUILIZER)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
11/12/2004
62LDA40METRONIDAZOLE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
75UNAPPROVED
New York District Office (NYK-DO)
10/20/2004
56YDA99ANTIBIOTIC N.E.C.
75UNAPPROVED
New York District Office (NYK-DO)
8/10/2004
62OCA10TERAZOSIN HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
3/25/2004
60LCA47PENTAZOCINE (ANALGESIC)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
2/27/2004
64BBA37SPIRONOLACTONE (DIURETIC)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
2/27/2004
62KBC10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
2/27/2004
62VBA01AMANTADINE HCL (ANTI-VIRAL)
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)

Frequently Asked Questions

What is First Flight Courier's FDA import refusal history?

First Flight Courier (FEI: 3003304350) has 12 FDA import refusal record(s) in our database, spanning from 2/27/2004 to 12/1/2006.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. First Flight Courier's FEI number is 3003304350.

What types of violations has First Flight Courier received?

First Flight Courier has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about First Flight Courier come from?

All FDA import refusal data for First Flight Courier is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.